Mounjaro 7.5 mg KwikPen, Once Weekly - 4 Doses

This medication is dispensed with a valid prescription only

What is Mounjaro?

Mounjaro (tirzepatide) is the first and only dual GIP and GLP-1 receptor agonist indicated for chronic weight management and type 2 diabetes. Mounjaro KwikPen is a multi-dose, pre-filled pen containing tirzepatide. Each pen delivers 4 doses.

What is Mounjaro used for?

1. Weight management

Mounjaro is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial Body Mass Index (BMI) of:

• 30 kg/m² (obesity) or


• ≥ 27 kg/m² to < 30 kg/m² (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes, or type 2 diabetes mellitus).

1. Type 2 diabetes mellitus

Mounjaro is indicated for the treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise:

• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications


• in addition to other medicinal products for the treatment of diabetes.

How do I take Mounjaro?

• The recommended starting dosage of Mounjaro is 2.5 mg injected subcutaneously once weekly.


• The 2.5 mg dosage is for treatment initiation and is not intended for glycemic control.


• After 4 weeks, increase the dosage to 5 mg injected subcutaneously once weekly.


• If needed to achieve individual treatment goals, dose increases can be made in 2.5 mg increments after a minimum of 4 weeks on the current dose.


• The maximum dosage of Mounjaro is 15 mg injected subcutaneously once weekly.


• If a dose is missed, instruct patients to administer Mounjaro as soon as possible within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once weekly dosing schedule.


• The day of weekly administration can be changed, if necessary, as long as the time between the two doses is at least 3 days (72 hours).

How do I inject Mounjaro?

• Mounjaro is to be injected subcutaneously in the abdomen, thigh or upper arm.


• The dose can be administered at any time of day, with or without meals.


• Injection sites should be rotated with each dose. If a patient also injects insulin, they should inject Mounjaro into a different injection site.

What are the common side effects of Mounjaro?

The common side effects are nausea, diarrhoea, vomiting, abdominal pain, and constipation.

Who should not use Mounjaro?

• A personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)


• Hypersensitivity to the active substance or to any of the excipients

Can I use Mounjaro during pregnancy?

There are no or a limited amount of data from the use of tirzepatide in pregnant women. Tirzepatide is not recommended during pregnancy and in women of childbearing potential not using contraception. If a patient wishes to become pregnant, or pregnancy occurs, tirzepatide should be discontinued. Tirzepatide should be discontinued at least 1 month before a planned pregnancy due to the long half-life.

Can I use Mounjaro while breast-feeding?

It is unknown whether tirzepatide is excreted in human milk. A risk to the newborn/infant cannot be excluded. A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from tirzepatide therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.

Product Details

• Active substance: Tirzepatide.


• Available strengths:
  
  
  
  • Mounjaro 2.5 mg/0.6 mL KwikPen solution for injection in pre-filled pen
  
  
  • Mounjaro 5 mg/0.6 mL KwikPen solution for injection in pre-filled pen
  
  
  • Mounjaro 7.5 mg/0.6 mL KwikPen solution for injection in pre-filled pen
  
  
  • Mounjaro 10 mg/0.6 mL KwikPen solution for injection in pre-filled pen
  
  
  • Mounjaro 12.5 mg/0.6 mL KwikPen solution for injection in pre-filled pen
  
  
  • Mounjaro 15 mg/0.6 mL KwikPen solution for injection in pre-filled pen
  
  
  
  


• Pack size: 1 pre-filled KwikPen (4 doses). Needles are not included.


• Shelf life: 2 years.


• Storage: Store in a refrigerator (2°C to 8°C). Do not freeze. Keep protected from light. After your first injection, you may keep the pen out of the refrigerator at up to 30°C for up to 30 days.